FN Media Group Presents USA News Group News Commentary

VANCOUVER, BC, Oct. 20, 2023 /PRNewswire/ -- USA News Group - According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic cancer increased by 1% from the previous year to 12%. The increase has generated more optimism from the Pancreatic Cancer Action Network (PanCAN), whose President and CEO Julie Fleshman, JD, MBA, stated, "It's an important milestone that shows we're headed in the right direction – and this means so much to all those affected by pancreatic cancer." Several biotech developers have been making strides against the deadly disease, including a new mRNA vaccine in the works from BioNTech SE (NASDAQ:BNTX), as well as promising drug-combo therapies from Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), Seagen Inc. (NASDAQ:SGEN), and better diagnostics from Myriad Genetics, Inc. (NASDAQ:MYGN) and Illumina, Inc. (NASDAQ:ILMN).